Production of struvite by magnesium anode constant voltage electrolytic crystallisation from anaerobically digested chicken manure slurry.

Nitrogen and phosphorus levels in livestock manure and digestive fluid are high, posing a threat to soil and water quality and necessitating nutrient removal and recovery. Phosphorus recovery has the potential to alleviate the global phosphorus resource crisis. This study proposed a magnesium anode constant voltage electrolysis method to crystallise struvite (magnesium ammonium phosphate hexahydrate, MgNH4PO4·6H2O) from anaerobically digested chicken manure slurry using reaction kinetics at variable constant voltages ranging from 2 V to 12 V. The recovery of nitrogen and phosphorus was shown to be effective over a wide initial pH range (3.00 ± 0.03-7.90 ± 0.10) using synthetic digestion fluids. Moreover, the pH gradually increased during the reaction without any external chemical adjustments. The phosphorus recovery rates conformed to the first-order kinetic model, with a maximum rate constant of 2.13 h-1. When the best voltage of 2 V was used at 25 ± 1 °C, the recovery rate reached 5.24 mg P h-1cm-2 in the synthetic digestion fluids during 90 min and 4.60 mg P h-1cm-2 in the anaerobically digested chicken manure slurry. The crystalline products recovered were identified as high-purity struvite by XRD and XPS. The purity of recovered struvite with an initial pH of 3.00 and 7.90 was 96.5% and 98.9%, respectively. These results demonstrated that the magnesium electrode could rapidly react with nitrogen and phosphorus to generate high-purity struvite.

Characterization of trace metal impact on organic acid metabolism and functional microbial community in treating dairy processing wastewater with thermophilic anaerobic membrane bioreactor.

The anaerobic digestion (AD) of dairy processing wastewater (DPW) to produce bioenergy is considered promising but also associated with the possibility of an unbalanced organic matter and trace metal (TM) content. In this study, the TM content and its impact on AD were determined in an anaerobic membrane bioreactor operated to treat DPW. The results indicated that a deficiency in TMs resulted in the slow deterioration of the process, reducing biogas production, disrupting the buffer system, and the massive accumulation of organic acid. The deficiency of Co/Ni was significant, while iron fluctuated due to microbial and chemical effects. Syntrophic propionate oxidizing bacteria and methanogen were the main groups suppressed under the TM deficient environment, resulting in AD failure. No inhibitory effect on the lactic acid metabolism was observed. Hence, supplying theoretical TM dosage to DPW was necessary to realize the efficient and stable AD process and robust microbial community.

Carbon-neutral treatment of N, N-dimethylformamide-containing industrial wastewater by anaerobic membrane bioreactor (AnMBR): Bio-energy recovery and CO2 emission reduction.

High-strength industrial wastewater containing approximately 2000 mg/L of N, N-dimethylformamide (DMF) was treated by the anaerobic membrane bioreactor (AnMBR) during a long-term operation with the concept of carbon neutrality in this study. Bio-methane was recovered as bio-energy or bio-resource from DMF-containing wastewater along with the CO2 emission reduction. The results are clear evidence of the feasibility of carbon-neutral treatment of DMF-containing wastewater by the AnMBR. With an effective degradation under the organic loading rate of 6.53 COD kg/m3/d at the HRT of 12 h, the AnMBR completely covered the energy consumption during long-term operation by saving electricity of 4.16 kWh/m3 compared with the conventional activated sludge process. The CO2 emission of the AnMBR was just 1.06 kg/m3, remarkably reducing 1.45 kg/m3 of CO2. The treatment of DMF-containing wastewater by the AnMBR perfectly realized the goal of carbon neutrality, and was considered as an alternative to the conventional activated sludge process.

Enhancement methane fermentation of Enteromorpha prolifera waste by Saccharomyces cerevisiae: batch kinetic investigation, dissolved organic matter characterization, and synergistic mechanism.

With the invasion of green tide, there were millions of tons of Enteromorpha prolifera (Enteromorpha) that need to be disposed of. An efficient microecological system for Enteromorpha fermentation was constructed using Saccharomyces cerevisiae (S. cerevisiae) and granular sludge at mesophilic condition (35 °C). In order to investigate the influence of S. cerevisiae dosage on fermentation, biomethane production and variations in dissolved organic matter (DOM) were investigated. The results indicated that the microecosystem with added S. cerevisiae exhibited improved fermentation capacity. Specifically, biomethane production was improved by 18%, with a maximum methane yield of 331 mL/g VS, and the time required to reach 90% methane yield was reduced by 41%. There were positive linear relationships between S. cerevisiae dosage and the efficiency of hydrolysis, acidogenesis, acetogenesis, and methanogenesis (R2 > 0.9). According to theoretical calculations, there was a positive effect of lower S. cerevisiae dosage (less than 0.93 g/g TS) on biomethane production, and excess dosage (more than 0.93 g/g TS) led to a negative effect due to volatile fatty acid (VFA) accumulation. The excitation-emission matrix (EEM) indicated that the humification index (HIX) and fulvic acid (FA) percentage of fluorescence regional integration in the system were decreased because the quinone and ketone groups of the FA accepted electrons from S. cerevisiae. These findings suggested that this microecosystem can accelerate fermentation speed (41%) and increase biomethane output (18.2%). The synergistic effect of Enteromorpha fermentation with Saccharomyces cerevisiae addition.

Accelerated bio-methane production rate in thermophilic digestion of cardboard with appropriate biochar: Dose-response kinetic assays, hybrid synergistic mechanism, and microbial networks analysis.

The effect of biochar on the thermophilic digestion of mono-cardboard was investigated. Compared with control group (T0), the maximum rate of biomethane production was significantly improved after the addition of biochar, especially, it has been improved by 40.6% in T1 (0.77 g/gTS sludge) with the methane production of 89.28 mL/gVS. Also, the addition of biochar improved the efficiency of acidogenesis and acetogenesis. However, adverse effects were observed with the biomethane production decreased by 33.98% and the lag phase extended by 35 h in T5 (3.86 g/gTS sludge). Especially, the results showed that the adsorption of biochar played important roles in digestion. In addition, acetoclastic Methanosaeta which considered to be involved in interspecific electron transfer (IET) was enriched after biochar added and the highest diversity of acetogens was obtained in T1. Oppositely, microbial networks analysis showed that the excessive biochar may destroy the diversity of microorganism drastically.

Revealing the correlation of biomethane generation, DOM fluorescence, and microbial community in the mesophilic co-digestion of chicken manure and sheep manure at different mixture ratio.

Batch co-digestion tests of chicken manure (CM) and sheep manure (SM) at different ratio (Rs/c) were conducted under mesophilic condition (35 °C). Batch kinetic analysis of bioCH4 production, excitation-emission matrix (EEM) fluorescence of dissolved organic matter (DOM), and microbial community were investigated. The well-fitted modified Gompertz model (R2, 0.98-0.99) resulted that the co-digestion markedly improved the methane production rate and shortened the lag phase time. The highest bioCH4 yield of 219.67 mL/gVSadd and maximum production rate of 0.378 mL/gVSadd/h were obtained at an optimum Rs/c of 0.4. Additionally, a significant variation of DOM was detected at the Rs/c of 0.4 with a consistent degradation of soluble microbial byproduct-like and protein-like organics. The positive synergy effects of co-digestion conspicuously enhanced the bioCH4 production efficiency. FI370 and NADH were significantly correlated to Rs/c (p < 0.05). Moreover, the correlations among process indicator, EEM-peaks and different environmental parameters were evaluated by Pearson correlation analysis. The high diversity of acetoclastic methanogens and hydrogenotrophic methanogens in the co-digestion improved the stability of process. Graphical Abstract.

Optimizing biomethane production of mesophilic chicken manure and sheep manure digestion: Mono-digestion and co-digestion kinetic investigation, autofluorescence analysis and microbial community assessment.

Optimization of mesophilic methane production from Chicken manure (CM) and Sheep manure (SM) at total solid (TS) of 8% and 1.6% were obtained by sequence tests in mono-digestion. However, the positive synergy of co-digestion with an optimum CM/SM of 2.5 (310 mLCH4/gVSadded) resulted in a high hydrolytic capacity and methane production. The modified Gompertz model (R2 > 0.98) and modified Aiba model (R2 > 0.88) illustrated co-digestion significantly improved the methane generation rate with strong ammonia tolerance. Dissolved Organic Matter (DOM) variation in response to the metabolic rate of microbial community illustrated that the SMP-like and protein-like components half-split by EEM-PARAFAC were significantly negative corresponded to bio-methane production. Moreover, the canonical correlation analysis (CCA) resulted a significant difference between the substrate and DOM composition. Potential functional metabolic illustrated statistically significance difference between mono and co-digestion, however, Methanosaeta and Syntrophobacter predominated the syntrophic methanogenesis. The constructed complex metabolic cooperation caused the co-digestion stable and high efficiency.

The auto fluorescence characteristics, specific activity, and microbial community structure in batch tests of mono-chicken manure digestion.

Batch tests inoculated with granular and suspended sludge of mono chicken manure (CM) digestion were conducted. Kinetic analysis showed a maximum bio-CH4 generation (6 mL/gVS/d) at an optimal TS of 10-12%. At a TS of 25%, serious inhibition was found for granular sludge and even greater inhibition for the suspended sludge caused by free ammonia. The auto fluorescence of Excitation-mission matrix with parallel factor analysis (PARAFAC) showed that the dissolved organic matter (DOM) varied between the form C1, C2, C3 and C4. The split component of the SMP-like C2 and protein-like C4 significantly related to the bio-methane production in time series. The canonical correlation analysis (CCA) indicated that ammonia, pH, and TS influenced the PARAFAC component significantly. The aceticlastic methanogens of the genus Methanosaeta and acetogens of the genus Syntrophobacter predominated in the CM sludge. The methanogens and acetogens formed a metabolic cooperation, making the process a stable methane produced activity.

Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.

BACKGROUND: A number of studies have investigated the association between androgenic alopecia (AGA) and cancer risk, but they have yielded inconsistent results. Therefore, this study was conducted to explore this controversial subject. METHODS: A literature database search was performed according to predefined criteria. An odds ratio (OR) or a hazard ratio (HR) with 95% confidence intervals (CIs) was retained to evaluate the relationship between the incidence of cancer or cancer-specific mortality and categories of AGA. Then a pooled OR or HR was derived. RESULTS: The pooled results showed that no specific degree of baldness had an influence on the incidence of cancer or cancer-specific mortality. However, AGA, especially frontal baldness, with the incidence of testicular germ cell tumor (TGCT) (OR = 0.69; 95% CI = 0.58-0.83). A significant increase of risk was observed in relation to high grade prostate cancer (PC) (OR = 1.42; 95% CI 1.02-1.99) and vertex with/without frontal baldness was associated with PC risk. CONCLUSIONS: The study results supported the hypothesis that AGA is negatively associated with TGCT risk and suggested an overlapping pathophysiological mechanism between them, while the viewpoint that AGA can be used as a phenotypic marker for PC risk was poorly supported.

Effectiveness of acupuncture for breast cancer related lymphedema: protocol for a single-blind, sham-controlled, randomized, multicenter trial.

BACKGROUND: Although various treatments for breast cancer related lymphedema exist, there is still a need for a more effective and convenient approach. Pilot studies and our clinical observations suggested that acupuncture may be a potential option. This study aims to verify the effectiveness of acupuncture on BCRL and evaluate its safety using a rigorously designed trial. METHODS/DESIGN: Women who are clinically diagnosed as unilateral BCRL, with a 10% to 40% increase in volume compared to the unaffected arm, will be recruited. Following baseline assessment, participants will be randomized to either the real acupuncture group or sham-acupuncture group at a ratio of 1:1, and given a standard real acupuncture or sham-acupuncture treatment accordingly on both arms followed by the same usual care of decongestive therapy. Volume measurements of both arms will be performed for every participant after each treatment. Data collected at baseline and the last session will be used to calculate the primary outcome and secondary outcomes. Other data will be exploited for interim analyses and trial monitoring. The primary outcome is the absolute reduced limb volume ratio. Secondary outcomes are incidence of adverse events and change in quality of life. A t test or non-parameter test will be used to compare the difference between two groups, and assess the overall effectiveness of acupuncture using the SPSS software (version 12). DISCUSSION: This study will help expand our knowledge about the effectiveness of acupuncture on BCRL, and how acupuncture might be used in the management of this condition. Acupuncture may be a promising complement or alternative to conventional lymphedema treatment methods, if its effectiveness is confirmed. TRIAL REGISTRATION: ClinicalTrials.gov NCT02803736 (Registered on October 31, 2016).

Efficacy and safety of Wuling San for treatment of breast-cancer-related upper extremity lymphoedema: study protocol for a pilot trial.

INTRODUCTION: Breast-cancer-related upper extremity lymphoedema (BCUL), a common complication of mastectomy, can cause physical discomfort, psychological distress, cosmetic defects, functional disability and chronic recurrent erysipelas in the affected arm(s). It is a challenge to physicians involved in the management of these patients. Wuling San, a classic prescription in Traditional Chinese Medicine used in treating oedema for thousands of years, is reported by many Chinese journals to perform well in BCUL. Therefore, the aim of this study is to verify its efficacy and evaluate its safety using rigorous methodological designs in patients with BCUL. METHODS AND ANALYSIS: To verify the efficacy and assess the safety of Wuling San over a placebo, this double-blind, randomised, placebo-controlled, multicentre trial will be carried out in three hospitals. A total of 200 eligible patients with BCUL will be randomly allocated, in a ratio of 1:1, to either the experimental medicine group or the placebo group. The primary outcome measure will be the proportion of absolute reduced limb volume, as measured by perometry. The second outcome measure will be the number of participants with adverse events. The assessment will be carried out at the following time points: before enrolment (baseline) and 2, 4, 6 and 8 weeks after treatment. ETHICS AND DISSEMINATION: This trial will be conducted in accordance with the Declaration of Helsinki and supervised by the institutional review board of the Fourth Affiliated Hospital of Guangxi Medical University (approval number PJK2016088). All patients will receive information about the trial in verbal and written forms and will give informed consent before enrolment. This trial will help to demonstrate whether Wuling San is effective in the treatment of patients with BCUL. The results will be published in peer-reviewed journals or disseminated through conference presentations. TRIAL REGISTRATION NUMBER: NCT02726477; Pre-results.

Role of IL-18 Gene Promoter Polymorphisms, Serum IL-18 Levels, and Risk of Hepatitis B Virus-related Liver Disease in the Guangxi Zhuang Population: a Retrospective Case-Control Study.

BACKGROUND: The aim of this study was to assess the relationship between IL-18 gene polymorphisms and HBV-related diseases and whether these polymorphisms influence its expression in the Guangxi Zhuang population. MATERIALS AND METHODS: We enrolled 129 chronic HBV infected (CHB) patients, 86 HBV-related liver cirrhosis (LC) patients and 160 healthy controls in our study. Polymerase chain reaction-restriction fragment length polymorphism methods were used to detect IL-18 gene -607C/A, -137G/C polymorphisms, and an ELISA kit was employed to determine serum IL-18 levels. RESULTS: No correlation was found between the -607C/A polymorphism and risk of HBV-related disease. For the -137G/C polymorphism, the GC genotype and C allele were associated with a significantly lower risk of CHB (95%CI: 0.32-0.95, p=0.034 and 95%CI: 0.35-0.91, p=0.018) and HBV-related LC (95%CI: 0.24-0.89, p=0.022 and 95%CI: 0.28-0.90, p=0.021). A similar decreased risk was also found with the A-607C-137 haplotype. With respect to IL-18 expression, it was significantly lower in both patient groups, but no association was noted between the two polymorphisms in the IL-18 gene and its expression. CONCLUSIONS: Our study indicated that the -137C allele in the IL-18 gene may be a protective factor for HBV-related disease, and serum IL-18 level may be inversely associated with CHB and HBV-related LC.

Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case-control study.

BACKGROUND: Interleukin (IL)-18 gene polymorphisms have been found to play multiple roles in various diseases. However, studies focused on its involvement in hepatocellular carcinoma (HCC) remains controversial, and no much study has taken IL-18 serum levels into consideration. This study investigates the association between IL-18 polymorphisms and risk of hepatitis B virus-related HCC and their impact on serum IL-18 serum levels. METHODS: A total of 153 patients and 165 healthy controls were enrolled in this study. Polymorphisms at positions -607C/A and -137G/C in the IL-18 gene were determined using the polymerase chain reaction-restriction fragment length polymorphism method. Serum IL-18 levels were determined with an ELISA kit. RESULTS: No relationship was found between the -607C/A polymorphism and an individual's susceptibility to HCC. For the -137G/C polymorphism, the GC genotype and C allele were found to be significantly associated with decreased HCC risk (OR 0.506, 95% CI 0.290-0.882, P = 0.016 and OR 0.520, 95% CI 0.332-0.814, P = 0.004, respectively). The A(-607)C(-137) haplotype was also associated with a significant decreased risk of HCC (OR 0.495, 95% CI 0.294-0.834, P = 0.007). Serum IL-18 levels were found to be significantly lower in HCC patients compared to the control group in both the overall population and subjects with the different SNPs. Further, no association was found between serum IL-18 levels and the different genotypes within the same SNP. CONCLUSION: These findings suggest that the -137G/C SNP in IL-18 may be a protective factor against HCC. Nevertheless, none of the studied SNPs was associated with the expression of IL-18.

Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study.

Reactive oxygen species (ROS) play critical roles in hepatocarcinogenesis. The catalase (CAT) enzyme is involved in the repair of ROS. Therefore, we investigate the association between CAT gene polymorphisms and the risk of hepatocellular carcinoma (HCC). A total of 715 subjects were divided into 4 groups: 111 chronic hepatitis B (CHB) patients, 90 hepatitis B virus (HBV)-related liver cirrhosis (LC) patients, 266 HBV-HCC patients, and 248 healthy controls. The polymerase chain reaction-restriction fragment length polymorphism strategy was used to detect CAT gene rs1001179, rs769217, and rs7943316 polymorphisms. Binary logistic regression analyses adjusting for sex, age, ethnicity, smoking and alcohol consumption, and body mass index suggested that subjects carrying the rs769217 T allele were at marginally increased risk of CHB, LC, and HCC, with adjusted odds ratios (ORs) of 1.51 (95% confidence interval [CI] = 1.04-2.20, P = 0.029), 1.48 (95% CI = 1.03-2.14, P = 0.035), and 1.51 (95% CI = 1.14-1.98, P = 0.004), respectively. Similarly, those individuals carrying the rs769217 TT genotype had a moderately increased risk of CHB, LC, and HCC, with adjusted ORs of 2.11 (95% CI = 1.05-4.22, P = 0.035), 2.00 (95% CI, 1.01-3.95, P = 0.047), and 1.93 (95% CI = 1.14-3.28, P = 0.015), respectively. Moreover, subjects carrying the rs769217 CT genotype and at least 1 copy of the T allele (dominant model) were 1.78 times and 1.83 times more likely to develop HCC, respectively (OR = 1.78, 95% CI = 1.16-2.73, P = 0.009 and OR = 1.83, 95% CI = 1.23-2.71, P = 0.003). This association between CAT rs769217 T alleles and HCC risk is significantly strengthened among men, nonsmokers, nondrinkers, and among individuals <50 years of age. Furthermore, we found 1 high-risk haplotype GTA for CHB (OR = 1.45, 95% CI = 1.05-2.01) and 1 protective haplotype GCA for HCC risk (OR = 0.67, 95% CI = 0.52-0.87). We did not found any significant difference in CAT rs1001179 and rs7943316 polymorphisms between controls and cases. Our findings suggest that the CAT rs769217 T allele is associated with increased risk of CHB, HBV-LC, and HBV-HCC in Guangxi population.

Meta-analysis of the association between CR1 polymorphisms and risk of late-onset Alzheimer's disease.

CR1 polymorphisms have been reported to be associated with late-onset Alzheimer's disease (LOAD) susceptibility. The findings of these studies, however, have been inconsistent. Therefore, we performed a meta-analysis to assess the association between CR1 variants and LOAD susceptibility. We retrieved all relevant studies of the associations between CR1 polymorphisms and the susceptibility to LOAD for the period up to March 30, 2014. The strength of the association between CR1 polymorphisms and LOAD risk was estimated by odds ratios (ORs) and their 95% confidence intervals (CIs). A total of 6 articles were eventually identified with 2752 LOAD cases and 2313 controls for the rs6656401 polymorphism, and 4 studies containing 2547 LOAD cases and 2338 controls were included for the rs3818361 polymorphism. Overall, the pooled data showed that the CR1 rs6656401 polymorphism was significantly associated with LOAD risk in the overall population (A vs. G: OR=1.32, 95%CI=1.17-1.50, P=0.000; AG+AA vs. GG: OR=1.39, 95%CI=1.20-1.61, P=0.000). With respect to the CR1 rs3818361 polymorphism, a statistically significant increased LOAD risk was observed in the overall population (T vs. C: OR=1.24, 95% CI=1.13-1.37, P=0.000; TT+TC vs. CC: OR=1.30, 95% CI=1.15-1.46, P=0.000; TT vs. TC+CC: OR=1.35, 95% CI=1.06-1.71, P=0.014). This meta-analysis demonstrated significant associations of both the CR1 rs6656401 and CR1 rs3818361 polymorphisms with LOAD susceptibility.

Lack of association of INS VNTR polymorphism with polycystic ovary syndrome: a meta-analysis.

PURPOSE: An association between the INS VNTR polymorphisms and polycystic ovary syndrome (PCOS) susceptibility has been reported in previous studies, but the results were inconsistent. This study was conducted to explore this association using meta-analysis. METHODS: PubMed, Embase, and China National Knowledge Infrastructure (CNKI) were searched according to predefined criteria for all relevant studies published up to August 2013. Four genetic models, together with odds ratios (ORs) and 95 % confidence intervals (CI), were calculated. Subgroup analyses were performed by ethnicity, anovulatory PCOS, and Hardy-Weinberg equilibrium (HWE) in the controls. RESULTS: In total, 13 case-control studies, including 1,767 cases and 4,108 controls, were included. No significant association was detected in overall population in all models (III/III vs. I/I: OR = 1.200, 95%CI = 0.866-1.664, P=0.277; I/III vs. I/I: OR = 1.041, 95%CI = 0.880-1.232, P=0.637; III/III + I/III vs. I/I: OR = 1.191, 95%CI = 0.912-1.554, P=0.199; III/III vs. I/III + I/I: OR = 1.100, 95%CI = 0.816-1.484, P=0.531), the same as in Caucasian and Asian populations. When the studies were limited to conform to HWE, the results remained persistent and robust. The anovulation subgroup showed significantly elevated risk in the I/III vs. I/I (OR = 1.460, 95%CI = 1.017-2.095, P=0.040). CONCLUSIONS: This meta-analysis revealed no significant association between INS VNTR polymorphisms and the risk of PCOS in the overall population, while it supported that variance may be associated with susceptibility to PCOS with anovulation. Further confirmation is needed from more well-designed and larger studies.